Pulmatrix Inc 最大收入来源是 Novel Class of Inhaled Therapeutic Products,在最近的收益报告中收入为 7,298,000。就地区而言, United States 是 Pulmatrix Inc 的主要市场,收入为 7,298,000。
Procaccianti Hotel REIT Inc 是否盈利?
不,根据最新的财务报表,Pulmatrix Inc 的净损失为 $-5
Procaccianti Hotel REIT Inc 有负债吗?
不,Pulmatrix Inc 的负债为 0
Procaccianti Hotel REIT Inc 的流通股有多少?
Pulmatrix Inc 的总流通股为 3.65
关键数据
前收盘价
--
开盘价
--
当日区间
-
52周范围
-
交易量
--
平均成交量
--
股息收益率
--
每股收益(TTM)
--
市值
--
什么是 PRXA?
Procaccianti Hotel REIT, Inc. operates as a real estate investment trust which focuses on hotel sector. The company is headquartered in Cranston, Rhode Island. The company went IPO on 2025-05-12. The firm acquires, owns and operates a diverse portfolio of hospitality properties consisting of primarily existing select-service, extended-stay, and compact full-service hotel properties throughout the United States. The firm owns interests in five select-service hotels located in four states with a total of 559 rooms.